ProBio
ProBio, a GenScript subsidiary, is a global CDMO specializing in end-to-end development and manufacturing of biologics, with strong expertise in bispecific antibodies. From discovery through GMP, we integrate advanced antibody engineering, cell line development, and scalable manufacturing to accelerate complex bispecific programs. Our multidisciplinary teams deliver customized solutions to address developability, functionality, and production challenges, helping biotech and pharma partners efficiently advance next-generation bispecific therapies to clinical and commercial milestones worldwide.
